Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation

Radioiodine (RAI)-refractory thyroid cancer is an uncommon entity, occurring with an estimated incidence of 4-5 cases/year/million people. RAI refractoriness is more frequent in older patients, in those with large metastases, in poorly differentiated thyroid cancer, and in those tumors with high 18-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Angelica, Iglesias, Laura, Klain, Michele, Pitoia, Fabián, Schlumberger, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522117/
https://www.ncbi.nlm.nih.gov/pubmed/28225999
http://dx.doi.org/10.1590/2359-3997000000245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522117/
https://www.ncbi.nlm.nih.gov/pubmed/28225999
http://dx.doi.org/10.1590/2359-3997000000245

Ejemplares similares